Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Griffiths

Showing results (131-140 of 248) with videos related to

Pageof 25
Sort By:
Chembiochem : a European Journal of Chemical Biology|July 12, 2013
Unusual tubulin-clustering ability of specifically c7-modified colchicine analoguesOlga N Zefirova, Heiko Lemcke, Margareta Lantow, et al.
Nature Cell Biology|November 5, 2003
Citron-N is a neuronal Rho-associated protein involved in Golgi organization through actin cytoskeleton regulationPaola Camera, Jorge Santos da Silva, Gareth Griffiths, et al.
Oncotarget|December 8, 2017
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trialSiân Pugh, Raphaële Thiébaut, John Bridgewater, et al.
The Lancet. Oncology|October 12, 2014
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trialAmanda Tristram, Christopher N Hurt, Tracie Madden, et al.
Frontiers in Cellular and Infection Microbiology|June 14, 2013
Actin-binding protein regulation by microRNAs as a novel microbial strategy to modulate phagocytosis by host cells: the case of N-Wasp and miR-142-3pPaulo Bettencourt, Sabrina Marion, David Pires, et al.
BMC Cancer|September 1, 2022
ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trialElizabeth Smyth, Kelly Cozens, Daniel Griffiths, et al.
European Journal of Cell Biology|June 29, 2010
Initial receptor-ligand interactions modulate gene expression and phagosomal properties during both early and late stages of phagocytosisEik Hoffmann, Sabrina Marion, Bibhuti Bhusan Mishra, et al.
BJU International|April 27, 2020
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatinRobert Jones, Simon Crabb, John Chester, et al.
Pilot and Feasibility Studies|August 7, 2019
HATRIC: a study of <i>Pelargonium sidoides</i> root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults-study protocol for a double blind, placebo-controlled randomised feasibility trialAmy Whitehead, Catherine Simpson, Merlin Willcox, et al.
Trials|October 23, 2014
Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trialDouglas Adamson, Jane Blazeby, Annmarie Nelson, et al.
Pageof 25

Showing results (131-140 of 248) with videos related to

Sort By:
Pageof 25
Chembiochem : a European Journal of Chemical Biology|July 12, 2013
Unusual tubulin-clustering ability of specifically c7-modified colchicine analoguesOlga N Zefirova, Heiko Lemcke, Margareta Lantow, et al.
Nature Cell Biology|November 5, 2003
Citron-N is a neuronal Rho-associated protein involved in Golgi organization through actin cytoskeleton regulationPaola Camera, Jorge Santos da Silva, Gareth Griffiths, et al.
Oncotarget|December 8, 2017
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trialSiân Pugh, Raphaële Thiébaut, John Bridgewater, et al.
The Lancet. Oncology|October 12, 2014
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trialAmanda Tristram, Christopher N Hurt, Tracie Madden, et al.
Frontiers in Cellular and Infection Microbiology|June 14, 2013
Actin-binding protein regulation by microRNAs as a novel microbial strategy to modulate phagocytosis by host cells: the case of N-Wasp and miR-142-3pPaulo Bettencourt, Sabrina Marion, David Pires, et al.
BMC Cancer|September 1, 2022
ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trialElizabeth Smyth, Kelly Cozens, Daniel Griffiths, et al.
European Journal of Cell Biology|June 29, 2010
Initial receptor-ligand interactions modulate gene expression and phagosomal properties during both early and late stages of phagocytosisEik Hoffmann, Sabrina Marion, Bibhuti Bhusan Mishra, et al.
BJU International|April 27, 2020
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatinRobert Jones, Simon Crabb, John Chester, et al.
Pilot and Feasibility Studies|August 7, 2019
HATRIC: a study of <i>Pelargonium sidoides</i> root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults-study protocol for a double blind, placebo-controlled randomised feasibility trialAmy Whitehead, Catherine Simpson, Merlin Willcox, et al.
Trials|October 23, 2014
Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trialDouglas Adamson, Jane Blazeby, Annmarie Nelson, et al.
Pageof 25